Company Quick10K Filing

Quick10K

⚲

Advantego

Filings

10-Q	2019-09-30	Filed 2019-11-19
10-Q	2019-06-30	Filed 2019-08-14
10-Q	2019-03-31	Filed 2019-05-15
10-K	2018-12-31	Filed 2019-04-01
10-Q	2018-09-30	Filed 2018-11-13
S-1	2018-08-02	Public Filing
10-Q	2018-06-30	Filed 2018-08-14
10-Q	2018-03-31	Filed 2018-05-21
10-K	2017-12-31	Filed 2018-04-02
10-Q	2017-09-30	Filed 2017-11-28
10-Q	2017-06-30	Filed 2017-11-22
10-Q	2017-03-31	Filed 2017-11-21
10-K	2016-12-31	Filed 2017-10-19
10-Q	2016-09-30	Filed 2017-04-05
10-Q	2016-06-30	Filed 2016-09-07
10-Q	2016-03-31	Filed 2016-05-05
10-K	2015-12-31	Filed 2017-08-04
10-Q	2015-06-30	Filed 2015-12-01
10-Q	2015-06-30	Filed 2015-12-01
10-Q	2015-03-31	Filed 2015-12-01
10-K	2014-12-31	Filed 2017-08-03
10-Q	2014-09-30	Filed 2015-11-25
10-Q	2014-06-30	Filed 2015-11-09
10-Q	2014-03-31	Filed 2015-11-04
10-K	2013-12-31	Filed 2017-03-27
10-Q	2013-09-30	Filed 2013-11-14
10-Q	2013-06-30	Filed 2013-08-14
10-Q	2013-03-31	Filed 2013-05-15
10-K	2012-12-31	Filed 2013-04-01
10-Q	2012-09-30	Filed 2012-11-14
10-Q	2012-06-30	Filed 2012-07-31
10-Q	2012-03-31	Filed 2012-05-11
10-K	2011-12-31	Filed 2012-03-30
10-Q	2011-09-30	Filed 2011-11-14
10-Q	2011-06-30	Filed 2011-08-15
10-Q	2011-03-31	Filed 2011-05-12
10-K	2010-12-31	Filed 2011-04-12
10-Q	2010-09-30	Filed 2010-11-22
10-Q	2010-06-30	Filed 2010-08-20
10-Q	2010-03-31	Filed 2010-05-24
10-K	2009-12-31	Filed 2010-05-14

Reports

8-K	2020-05-20
8-K	2020-05-19
8-K	2020-03-30
8-K	2020-03-06
8-K	2020-02-28
8-K	2020-01-17
8-K	2019-12-12
8-K	2019-05-26
8-K	2019-03-14
8-K	2019-01-14
8-K	2018-12-18
8-K	2018-07-20
8-K	2018-06-11
8-K	2018-05-31
8-K	2018-03-02
8-K	2018-02-05
8-K	2018-01-31

Advantego Financials

ADGO Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin


Comps ($'000 TTM)	Market Cap	Gross Margin	EV/EBITDA	Ret on Assets	Assets	Liabilities	Revenue	G Profit	Net Income	EBITDA	EV
11 Good Energy (ELVN)
1347 Capital Corp (TFSC)
1Life Healthcare (ONEM)
1PM Industries (OPMZ)
1st Century Bancshares (FCTY)
1st Financial Services Corp (FFIS)
1st United Bancorp (FUBC)
2-Track Global (TTG)
20 20 Global (TWGL)
111 (YI)				0%	1,546,418	322,654	0	0	0	0	-853,740
1 800 Flowers Com (FLWS)	944,324	42%	13.3	6%	664,955	335,559	1,266,390	533,727	36,761	75,090	1,000,932
10x Genomics (TXG)	4,804,979	75%	-490.3	-2%	572,815	151,367	61,207	45,727	-9,603	-8,887	4,357,180
12 Retech (RETC)	0	32%	-0.1	-1,385%	1,118	20,421	625	199	-15,491	-14,800	966
1347 Property Insurance Holdings (PIH)	33,711	0%	0.4	-5%	164,088	108,405	18,194	0	-7,969	-8,017	-2,855
21st Century Oncology Holdings (RTSX)
180 Degree Capital (TURN)
1847 Holdings (EFSH)		25%	-2.4	-15%	18,527	23,194	27,219	6,699	-2,862	-1,433	3,396
1895 Bancorp of Wisconsin (BCOW)	46,152,715		12,508.1	-0%	441,187	382,722	0	0	-44	3,689	46,142,359
1st Constitution Bancorp (FCCY)	164,504	0%	4.4	1%	1,342,565	1,204,038	490	0	13,787	32,503	143,748
024 Pharma (EEIG)


Balance Sheet ($'000)	2011-09-30	2011-12-31	2012-03-31	2012-06-30	2012-09-30	2012-12-31	2013-03-31	2013-06-30	2013-09-30	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-12-31	2019-03-31	2019-06-30
Cash	271	119	78	39	9	8	18	4	14	3	13	0	46	44	15	2	37	92	423	135
Accounts Receivable	9	7	8	1	0	0									2	6		25	21	68
Inventory																	1	6	5	0
PP&E	3,989	3,989	3,989	3,980	3,980	3,980	3,980	3,980	3,980	350	350	350
Assets	4,723	4,566	4,498	4,385	4,283	4,103	4,028	3,986	3,997	354	364	350	46	44	18	8	38	195	546	554
Accounts Payable										12	9	4	4	4	4	8	27	16	70	112
Long-Term Debt						350							43	95
Liabilities	283	130	145	7	384	376	403	435	748	757	856	925	196	358	492	612	650	1,656	4,445	4,782
Stockholders' Equity	4,440	4,436	4,353	4,377	3,899	3,727	3,625	3,551	3,249	-403	-492	-575	-150	-314	-474	-604	-612	-1,461	-3,899	-4,228


Income Statement ($'000)	2011-09-30	2011-12-31	2012-03-31	2012-06-30	2012-09-30	2012-12-31	2013-03-31	2013-06-30	2013-09-30	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-12-31	2019-03-31	2019-06-30
Revenue	0	0	0	0	0	0	0	0	0					0	3	6			8	21
Cost of Revenue																			11	15
Gross Profit																			-3	6
R&D
SG&A	222	169	173	153	93	76	87	66	27				-27	160	158	130	124		348	304
Tax	0	0	0	0	0	0	0	0	0	0				0	0	0	0		0	0
Net Income	-249	-79	-229	-237	-482	-189	-291	62	-303	-3,670			2	-165	-160	-130	-163		-600	-745


Cash Flow ($'000)	2011-09-30	2011-12-31	2012-03-31	2012-06-30	2012-09-30	2012-12-31	2013-03-31	2013-06-30	2013-09-30	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-12-31	2019-03-31	2019-06-30
Cash Operating		-149	-146	-131	-413	-130	-64	-33	-316	250			-6	-52	-41		-77		-557	-772
Cash Investing		-3	105	26	33	129	74	19	0	1									0	0
Cash Financing		0	0	66	350				327	-262				50	12		112		889	484